E-LIB Suche - Ergebnisse für: Meriranta, Leo

1

Inflammatory and subtype-dependent serum protein signatures..:

Arffman, Maare ; Meriranta, Leo ; Autio, Matias...
Med. 5 (2024) 6 - p. 583-602.e5 , 2024

Link: https://doi.org/10.1016/..

2

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signal..:

Meriranta, Leo ; Sorri, Selma ; Huse, Kanutte...
Blood Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

3

MRD-driven treatment with venetoclax-R2 in mantle cell lymp..:

Jerkeman, Mats ; Kolstad, Arne ; Hutchings, Martin...
Blood Advances. 8 (2024) 2 - p. 407-415 , 2024

Link: https://doi.org/10.1182/..

4

The DLBCL90 gene‐expression assay identifies double‐hit lym..:

Isaksen, Kathrine T. ; Beiske, Klaus ; Smeland, Erlend B....
eJHaem. 2 (2020) 1 - p. 104-108 , 2020

Link: https://doi.org/10.1002/..

5

Patients with high-risk DLBCL benefit from dose-dense immun..:

Holte, Harald ; Karjalainen-Lindsberg, Marja-Liisa ; Beiske, Klaus...
Blood Advances. 4 (2020) 9 - p. 1906-1915 , 2020

Link: https://doi.org/10.1182/..

6

Molecular background delineates outcome of double protein e..:

Meriranta, Leo ; Pasanen, Annika ; Alkodsi, Amjad...
Blood Advances. 4 (2020) 15 - p. 3742-3753 , 2020

Link: https://doi.org/10.1182/..

7

Distinct subtypes of diffuse large B-cell lymphoma defined ..:

Alkodsi, Amjad ; Cervera, Alejandra ; Zhang, Kaiyang...
Leukemia. 33 (2019) 11 - p. 2662-2672 , 2019

Link: https://doi.org/10.1038/..

8

Genetic and Functional Drivers of Diffuse Large B Cell Lymp..:

Reddy, Anupama ; Zhang, Jenny ; Davis, Nicholas S....
Cell. 171 (2017) 2 - p. 481-494.e15 , 2017

Link: https://doi.org/10.1016/..

9

MRD-driven treatment with venetoclax-R2 in mantle cell lymp..:

Jerkeman, Mats ; Kolstad, Arne ; Hutchings, Martin...
https://vbn.aau.dk/da/publications/e1016e94-29e3-4637-ba18-dd36853a40fa. , 2024

Link: https://vbn.aau.dk/da/pu..

10

The DLBCL90 gene-expression assay identifies double-hit lym..:

Isaksen, Kathrine T ; Beiske, Klaus ; Smeland, Erlend B...
10.1002/jha2.109. , 2022

Link: http://hdl.handle.net/10..

11

Immunogenomic Landscape of Hematological Malignancies:

Dufva, Olli ; Pölönen, Petri ; Brück, Oscar...
10.1016/j.ccell.2020.06.002. , 2021

Link: http://hdl.handle.net/10..

12

Patients with high-risk DLBCL benefit from dose-dense immun..:

Leppä, Sirpa ; Jørgensen, Judit ; Tierens, Anne...
Leppä , S , Jørgensen , J , Tierens , A , Meriranta , L , Østlie , I , de Nully Brown , P , Fagerli , U M , Larsen , T S , Mannisto , S , Munksgaard , L , Maisenhölder , M , Vasala , K , Meyer , P , Jerkeman , M , Björkholm , M , Fluge , Ø , Jyrkkiö , S , Liestøl , K , Ralfkiaer , E , Spetalen , S , Beiske , K , Karjalainen-Lindsberg , M L & Holte , H 2020 , ' Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis ' , Blood advances , vol. 4 , no. 9 , pp. 1906-1915 . https://doi.org/10.1182/bloodadvances.2020001518. , 2020

Link: https://portal.findresea..

13

Distinct subtypes of diffuse large B-cell lymphoma defined ..:

Alkodsi, Amjad ; Cervera, Alejandra ; Zhang, Kaiyang...
10.1038/s41375-019-0509-6. , 2020

Link: http://hdl.handle.net/10..

14

Diffuusin suurisoluisen B-solulymfooman nykyhoito:

Leppä, Sirpa ; Meriranta, Leo ; Pasanen, Annika.
Leppä , S , Meriranta , L , Pasanen , A & Jyrkkiö , S 2019 , ' Diffuusin suurisoluisen B-solulymfooman nykyhoito ' , Duodecim , Vuosikerta. 135 , Nro 12 , Sivut 1185-1192 .. , 2020

Link: http://hdl.handle.net/10..

15

Patients with high-risk DLBCL benefit from dose-dense immun..:

Leppä, Sirpa ; Jørgensen, Judit ; Tierens, Anne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218416/. , 2020

Link: http://www.ncbi.nlm.nih...